FLT1, Human (Icrucumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-FLT1, Human (Icrucumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityFLT1, Human (Icrucumab biosimilar)
CloneIcrucumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG1 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
ApplicationsNeut, ELISA, IF, IP, FuncS, FCM, ICC
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human FLT1 Recombinant Antibody. Icrucumab (IMC-18F1) is a human monoclonal antibody designed for the treatment of solid tumors. Icrucumab was developed by ImClone Systems Inc. It is undergoing Phase I trials.
Immunogenn/a
Other NamesAnti-FLT1 Recombinant Antibody, Research Grade Icrucumab, Anti-Human FLT1 Recombinant Antibody, 18F1, IMC-18F1, LY3012212, Antibody Drug Analogues, Monoclonal Antibody, YR1244, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 1024603-92-6
Catalog #YR1244
Priceplease inquire
Order / More InfoFLT1, Human (Icrucumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.